Fusion Antibodies (FAB) News Today GBX 4.20 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Fusion Antibody Share Chat (FAB)October 26, 2024 | lse.co.ukFusion Antibodies plc (LON:FAB) Insider Adrian Kinkaid Buys 83,728 SharesOctober 17, 2024 | insidertrades.com'Positive momentum' builds at Belfast's Fusion AntibodiesOctober 10, 2024 | msn.comRichard John Buick Acquires 94,825 Shares of Fusion Antibodies plc (LON:FAB) StockSeptember 10, 2024 | insidertrades.comFusion Antibodies Full Year 2024 Earnings: EPS Misses ExpectationsSeptember 7, 2024 | finance.yahoo.comAdrian Kinkaid Purchases 120,000 Shares of Fusion Antibodies plc (LON:FAB) StockSeptember 6, 2024 | insidertrades.comRevenues collapse after ‘challenging year’ at Fusion AntibodiesSeptember 5, 2024 | msn.comArtificial sun: Nuclear fusion closes in, new method can tackle key challengesAugust 26, 2024 | msn.comFusion Antibodies plc (LON:FAB) Insider Acquires £4,500 in StockJuly 23, 2024 | insidertrades.comResearch Reveals Conserved Neutralizing Epitope in Herpesvirus gB ProteinFebruary 27, 2024 | msn.comFusion Antibodies PLC (FAB)February 22, 2024 | uk.investing.comFusion Antibodies gets tax credit from UK HMRC for OptiMAL platformFebruary 2, 2024 | lse.co.ukFusion Antibody Share ChatJanuary 22, 2024 | lse.co.ukHIV antibodies protect animals in proof-of-concept studyJanuary 17, 2024 | msn.comFusion Antibodies PLC Ordinary Shares FABJanuary 9, 2024 | morningstar.comStudy suggests omicron subvariant causes enhanced fusion with human lung cellsJanuary 8, 2024 | msn.comFusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% UpsideDecember 20, 2023 | markets.businessinsider.comFusion Antibodies Shares Rise on US Cancer Institute CollaborationNovember 28, 2023 | marketwatch.comBelfast antibodies firm Fusion flags up 'challenges'November 9, 2023 | msn.comNew cancer therapy using antibody could offer a less toxic treatment option, study showsOctober 31, 2023 | news.yahoo.comFusion Antibodies Full Year 2023 Earnings: UK£0.10 loss per share (vs UK£0.046 loss in FY 2022)October 1, 2023 | finance.yahoo.comFusion Antibodies Pretax Loss Widens on Higher Costs, Lower RevenueSeptember 29, 2023 | marketwatch.comIntroducing NeoMab™: GemPharmatech's Innovative Antibody Gene Humanized Mouse ModelAugust 23, 2023 | markets.businessinsider.comFusion Antibodies Signs Combined Screening Service With AI CompanyAugust 21, 2023 | marketwatch.comTonix Pharmaceuticals Initiates Phase 1 Trial of TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy VolunteersAugust 16, 2023 | finance.yahoo.comFusion Antibodies Shares Dive After Discounted PlacingMay 19, 2023 | marketwatch.comAntibody Engineering Services Market Growth, Business Overview 2023, and Forecast to 2030 | Fusion Antibodies, Absolute Antibody, Creative BiolabsMay 16, 2023 | marketwatch.comResurrection Of Covid Antibody Therapy: IgG3 Fc Fusion To The RescueApril 28, 2023 | forbes.comAntibody Engineering Services Market Growth by 2031April 27, 2023 | marketwatch.comAntibody Engineering Services Market Projected Industry Expansion and Factors Impacting Competitors, Alongside Promising Strategies Until 2029April 20, 2023 | marketwatch.comRecombinant Therapeutic Antibodies and Proteins Market: Key Players and Strategies for Future Growth by 2023-2030April 19, 2023 | marketwatch.comFusion (FUSN) to Begin Clinical Study on Targeted Alpha TherapyApril 13, 2023 | msn.comFusion Antibodies Files Patent Application for Cancer Treatment AntibodiesMarch 21, 2023 | marketwatch.comSleep deprivation could reduce vaccine antibodies, new study foundMarch 15, 2023 | foxnews.comFusion Antibodies Sees Lower FY 2023 Revenue On Order DelaysMarch 6, 2023 | marketwatch.comIn Depth Research on Recombinant Therapeutic Antibodies and Proteins Market Report 2023-2029March 1, 2023 | marketwatch.comAntibody Engineering Services Market | Rising Sales of the Industry Are Set To Drive for Growth Prospects and InnovationsFebruary 6, 2023 | marketwatch.comBivalent Antibodies For Covid-19: Two Hands Are Better Than OneJanuary 21, 2023 | forbes.comCancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to SectorNovember 28, 2022 | finance.yahoo.comNew Monoclonal Antibody Cocktail Neutralizes Lassa VirusNovember 3, 2022 | forbes.comAs Protection From Current Covid-19 Monoclonal Antibody Treatments Fades, The Discovery Of A New Class Of Antibodies Brings HopeOctober 27, 2022 | forbes.comRecombinant Therapeutic Antibodies and Proteins Market 2022 Giants Spending Is Going To Boom In 2028October 21, 2022 | marketwatch.comThe New Bivalent Booster Increases Antibodies to Fight Omicron, Data ShowOctober 18, 2022 | time.com86% of kids under 17 have antibodies from a past COVID infection, CDC data showsOctober 10, 2022 | abcnews.go.comDiagnostic Specialty Antibodies Market Size And Opportunities for New Players, Forecast from 2022 To 2028September 20, 2022 | marketwatch.comFusion Antibodies Plc (FAB.L)September 12, 2022 | uk.finance.yahoo.comProgress In The Search For Broadly Neutralizing Monoclonal Antibodies VIISeptember 7, 2022 | forbes.comProgress In The Search For Broadly Neutralizing Monoclonal Antibodies VISeptember 1, 2022 | forbes.comFusion Pharmaceuticals Announces First Patient Dosed in Phase 1/2 Study of FPI-1966 In Patients with Advanced Solid Tumors Expressing FGFR3August 29, 2022 | finance.yahoo.comFusion Antibodies sees revenue growth on transient expression serviceAugust 24, 2022 | lse.co.uk Get Fusion Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for FAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon knows the truth, which is why they want him silenced (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, FAB Media Mentions By Week FAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FAB News Sentiment▼0.670.45▲Average Medical News Sentiment FAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FAB Articles This Week▼00▲FAB Articles Average Week Get Fusion Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for FAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Oncimmune News OptiBiotix Health News Synairgen News ImmuPharma News IXICO News Oxford BioDynamics News Destiny Pharma News ValiRx News ReNeuron Group News Physiomics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:FAB) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Antibodies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FAB Stock Alerts